dsRNAContamination_mRNAVaccine_QualityChecker

dsRNA Contamination mRNA Vaccine

Huvac human vaccines vaccination adjuvants mRNA vaccines sterility endotoxins cold chain

Utility description: dsRNA Contamination mRNA Vaccine

dsRNA Contamination mRNA Vaccine Quality Checker — dsRNA Control in mRNA Vaccines

ℹ️ Utility performs quality control of mRNA products, focusing on determination of double-stranded RNA (dsRNA) levels according to FDA and EMA guidelines:
• Quantitative Analysis: Assessment of dsRNA percentage relative to total RNA mass.
• Detection Methods: Support for data from J2-ELISA (gold standard), HPLC, and capillary electrophoresis.
• Safety Assessment: Identification of risk for non-specific immune system activation (interferon response).
• Purity Control: Check of A260/A280 ratio to exclude protein contamination.

⚠️ IMPORTANT:
• dsRNA is formed as a byproduct during in vitro transcription.
• Even low levels of dsRNA can significantly reduce target antigen expression.

Usage:
dsRNAContamination_mRNAVaccine_QualityChecker.exe → demo mode (console output)
dsRNAContamination_mRNAVaccine_QualityChecker.exe input.csv output.json → evaluate your data

Input format:
BatchNumber,ProductName,dsRNA_Percent,Max_dsRNA_Limit,DetectionMethod,mRNA_Concentration_ng_ul,Min_Concentration_ng_ul,Purity_A260_A280

Example:
MRNA-001,Vaccine X,0.45,1.0,J2-ELISA,120.5,100.0,2.05

📍 Scope of Application (Usage Where):
• mRNA Vaccine Production: Quality control after purification stage.
• Drug Development: Optimization of IVT and purification processes.
• Regulatory Dossier: Preparation of impurity data for registration.
• Laboratory Control: Daily monitoring of synthesis quality.

— WHY IS THIS NEEDED?
Double-stranded RNA is recognized by cellular sensors (PKR, OAS, RIG-I) as a viral threat.
This leads to translation arrest and mRNA degradation, rendering the vaccine ineffective.
Strict dsRNA control guarantees high immunogenicity and product safety for the patient.

⚠️ CRITICAL:
• dsRNA Limit: Typically set at <1% or <2% depending on the platform.
• J2-ELISA Method: Most sensitive method for detecting long dsRNA molecules.
• Purity: Low A260/A280 ratio (<1.8) indicates protein or phenol contamination.
• Concentration: Sufficient concentration is necessary for impurity analysis accuracy.

Key features:
• Automatic dsRNA level check against specification
• Support for various analytical methods
• Comprehensive purity and concentration assessment
• Report generation for LIMS integration
• Compliance with GMP requirements for gene therapy

Critical parameters:
• dsRNA Content: < Spec Limit (e.g., 1.0%)
• Purity (A260/A280): > 1.8
• Concentration: > Min Limit
• Detection Method: Validated

💡 Usage tips:
1. Standard Calibration: Use known dsRNA standards for ELISA calibration.
2. Purification: Consider chromatography optimization upon high dsRNA levels.
3. Storage: Avoid multiple freeze-thaw cycles affecting RNA structure.
4. Documentation: Save raw optical density or chromatogram data.
5. Method Validation: Method must be validated for specificity and sensitivity.

⚠️ Note: This utility is a quality control tool. It does not replace functional tests (in vitro translation) or in vivo safety tests but serves as an important indicator of product purity.

input.csv

BatchNumber,ProductName,dsRNA_Percent,Max_dsRNA_Limit,DetectionMethod,mRNA_Concentration_ng_ul,Min_Concentration_ng_ul,Purity_A260_A280
MRNA-2026-VAC-001,SARS-CoV-2 mRNA Vaccine,0.45,1.0,J2-ELISA,120.5,100.0,2.05
MRNA-2026-VAC-002,Influenza mRNA Vaccine,1.85,1.0,HPLC,115.0,100.0,1.95
MRNA-2026-VAC-003,Zika mRNA Vaccine,0.12,0.5,CE,98.0,100.0,2.10

URS & FS — User Requirements and Functional Specification

This document describes the controlled interface and behaviour of dsRNAContamination_mRNAVaccine_QualityChecker for dsRNA Contamination mRNA Vaccine Quality Checker.

Domain limits URS input.csv FS IQ/OQ/PQ

Domain limits and critical parameters

Key fragments from the source description are shown below. Before production use, limits must be verified against the approved specification, registration dossier and local SOPs.

• Purity Control: Check of A260/A280 ratio to exclude protein contamination.
BatchNumber,ProductName,dsRNA_Percent,Max_dsRNA_Limit,DetectionMethod,mRNA_Concentration_ng_ul,Min_Concentration_ng_ul,Purity_A260_A280
• Regulatory Dossier: Preparation of impurity data for registration.
⚠️ CRITICAL:
• dsRNA Limit: Typically set at <1% or <2% depending on the platform.
• Purity: Low A260/A280 ratio (<1.8) indicates protein or phenol contamination.
• Concentration: Sufficient concentration is necessary for impurity analysis accuracy.
• Comprehensive purity and concentration assessment
• Compliance with GMP requirements for gene therapy
Critical parameters:
• dsRNA Content: < Spec Limit (e.g., 1.0%)
• Purity (A260/A280): > 1.8
• Concentration: > Min Limit
5. Method Validation: Method must be validated for specificity and sensitivity.
⚠️ Note: This utility is a quality control tool. It does not replace functional tests (in vitro translation) or in vivo safety tests but serves as an important indicator of product purity.

URS — User Requirements Specification

ID	Requirement	Criticality	Acceptance criterion
URS-001	The utility shall accept an input.csv file for dsRNA Contamination mRNA Vaccine Quality Checker with headers defined in the data contract.	High	The file is processed without manual header editing.
URS-002	The utility shall perform deterministic QC evaluation without machine learning and without probabilistic conformance decisions.	High	Identical input data, rule version and configuration produce reproducible results.
URS-003	The utility shall validate mandatory fields, data types, ranges, units and domain plausibility.	High	Schema, conversion and range errors are explicitly reported.
URS-004	The utility shall apply domain limits and rules from the description, approved specification, registration dossier and local SOPs.	High	Each check has PASS/WARNING/FAIL and a clear message.
URS-005	The utility shall generate output.json with machine-readable results, source values, warnings, failures and critical findings.	High	JSON is suitable for LIMS/ELN/MES integration and QA/QC review.
URS-006	The utility shall preserve traceability between batch/sample, input file, applied rules and final status.	High	Output contains identifiers, checked parameters and audit metadata.
URS-007	The documentation shall support IQ/OQ/PQ, CSV/CSA and review by internal QA or inspectors.	Medium	URS, FS, input/output contract and test scenarios are supplied with the utility.
URS-008	The utility shall be used as a QC decision-support tool and not as a substitute for approved specifications and QA/QP release decision.	Medium	Documentation states change control and limit-verification expectations.

input.csv contract

#	Field	Type	Sample	Purpose
1	`BatchNumber`	string / controlled vocabulary	`MRNA-2026-VAC-001`	Batch or lot identifier used for traceability.
2	`ProductName`	string / controlled vocabulary	`SARS-CoV-2 mRNA Vaccine`	Product or dosage-form name under evaluation.
3	`dsRNA_Percent`	decimal	`0.45`	Biological/molecular component controlled as a CQA.
4	`Max_dsRNA_Limit`	decimal	`1.0`	Biological/molecular component controlled as a CQA.
5	`DetectionMethod`	string / controlled vocabulary	`J2-ELISA`	Method or process approach; controlled reference value.
6	`mRNA_Concentration_ng_ul`	decimal	`120.5`	Component ratio; structural or formulation CQA.
7	`Min_Concentration_ng_ul`	decimal	`100.0`	Component ratio; structural or formulation CQA.
8	`Purity_A260_A280`	decimal	`2.05`	Purity or impurity profile; key QC parameter.

BatchNumber,ProductName,dsRNA_Percent,Max_dsRNA_Limit,DetectionMethod,mRNA_Concentration_ng_ul,Min_Concentration_ng_ul,Purity_A260_A280
MRNA-2026-VAC-001,SARS-CoV-2 mRNA Vaccine,0.45,1.0,J2-ELISA,120.5,100.0,2.05
MRNA-2026-VAC-002,Influenza mRNA Vaccine,1.85,1.0,HPLC,115.0,100.0,1.95
MRNA-2026-VAC-003,Zika mRNA Vaccine,0.12,0.5,CE,98.0,100.0,2.10

Input validation rules

ID	Field	Rule	Criticality
VR-001	`BatchNumber`	The field shall match an approved dictionary or accepted string representation.	High
VR-002	`ProductName`	The field shall match an approved dictionary or accepted string representation.	High
VR-003	`dsRNA_Percent`	The field shall match an approved dictionary or accepted string representation.	High
VR-004	`Max_dsRNA_Limit`	The field shall match an approved dictionary or accepted string representation.	Medium
VR-005	`DetectionMethod`	The field shall match an approved dictionary or accepted string representation.	Medium
VR-006	`mRNA_Concentration_ng_ul`	The field shall match an approved dictionary or accepted string representation.	Medium
VR-007	`Min_Concentration_ng_ul`	The field shall match an approved dictionary or accepted string representation.	Medium
VR-008	`Purity_A260_A280`	The field shall match an approved dictionary or accepted string representation.	Medium

FS — Functional Specification

ID	Function	Implementation
FS-001	CLI execution	Support execution modes: demo mode without arguments and production mode input.csv output.json.
FS-002	CSV import	Read input.csv in UTF-8/CSV-compatible format and validate header and expected columns.
FS-003	Schema validation	Check mandatory fields, column count, unknown key fields and empty mandatory values.
FS-004	Type conversion	Convert numeric, flag and text values; invalid format is recorded as a row-level error.
FS-005	Domain rule engine	Apply rules for dsRNA Contamination mRNA Vaccine Quality Checker, including critical limits from the description and approved specification.
FS-006	Status aggregation	Produce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance.
FS-007	JSON export	Write output.json with detailed checks, source values, warnings, failures and critical findings.
FS-008	Audit support	Keep result structure suitable for review, deviation investigation and calculation reproduction.
FS-009	Integration contract	Support the scenario LIMS/ELN/MES → input.csv → utility → output.json → portal/admin review.
FS-010	Error handling	Return explicit messages for missing file, empty CSV, invalid schema, output write failure and invalid format.

Example output.json

{
  "utilityId": "dsrnacontamination-mrnavaccine-qualitychecker",
  "utilityFolder": "dsRNAContamination_mRNAVaccine_QualityChecker",
  "package": "huvac",
  "overallStatus": "PASS|WARNING|FAIL",
  "sourceFile": "input.csv",
  "processedAtUtc": "2026-06-10T00:00:00Z",
  "checks": [
    {
      "parameter": "BatchNumber",
      "value": "MRNA-2026-VAC-001",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-001"
    },
    {
      "parameter": "ProductName",
      "value": "SARS-CoV-2 mRNA Vaccine",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-002"
    },
    {
      "parameter": "dsRNA_Percent",
      "value": "0.45",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-003"
    },
    {
      "parameter": "Max_dsRNA_Limit",
      "value": "1.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-004"
    },
    {
      "parameter": "DetectionMethod",
      "value": "J2-ELISA",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-005"
    },
    {
      "parameter": "mRNA_Concentration_ng_ul",
      "value": "120.5",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-006"
    },
    {
      "parameter": "Min_Concentration_ng_ul",
      "value": "100.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-007"
    },
    {
      "parameter": "Purity_A260_A280",
      "value": "2.05",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-008"
    }
  ],
  "criticalFindings": [],
  "warnings": [],
  "audit": {
    "inputHash": "sha256:<calculated at runtime>",
    "rulesVersion": "<utility executable version>",
    "documentation": "dsRNAContamination_mRNAVaccine_QualityChecker.documentation.html"
  }
}

Traceability matrix

URS	FS	Test	Evidence
URS-001	FS-001, FS-002	OQ-001	Verify execution and import of valid input.csv.
URS-002	FS-005, FS-006	OQ-004	Repeat the same dataset and compare output.json.
URS-003	FS-003, FS-004, FS-010	OQ-002, OQ-003	Verify missing columns and invalid types.
URS-004	FS-005, FS-006	OQ-004, PQ-001	Verify critical deviations on real/boundary data.
URS-005	FS-007, FS-009	OQ-005	Verify JSON schema and downstream-system suitability.
URS-006	FS-008	OQ-006	Verify identifiers and audit metadata.
URS-007	FS-008, FS-010	IQ-001, OQ-007	Verify documentation completeness and control evidence.
URS-008	FS-005, FS-008	PQ-002	Verify review workflow and no replacement of QA decision.

IQ/OQ/PQ test scenarios

ID	Scenario	Expected result
IQ-001	Verify executable, input.csv, documentation and checksum availability.	Delivery set is complete; version is recorded.
OQ-001	Valid sample row from input.csv.	PASS or acceptable WARNING according to rules.
OQ-002	Remove a mandatory CSV column.	Schema error or FAIL with missing-column reference.
OQ-003	Place a non-numeric value into a numeric field.	Type-conversion error with row/field reference.
OQ-004	Set a critical parameter outside the limit.	FAIL and critical finding.
OQ-005	Verify output.json structure.	All mandatory sections are present and JSON is valid.
OQ-006	Verify batch/sample traceability.	Input and result identifiers match.
PQ-001	Verify 3–5 real user batches/samples.	Result is confirmed by QC/QA review.
PQ-002	Verify deviation workflow and manual QA decision.	Utility supports review but does not replace approved decision.

QA/QC and change control

Do not rename columns without updating validator, documentation and test set.
Retain input.csv, output.json, executable version and checksum.
Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
Critical limits shall be verified against the approved specification, registration dossier and local SOPs.
The utility provides structured QC decision support; final release decision remains with QA/QP and approved procedures.

Included in packages

Biopharmaceuticals Extended QC Suite

Extended QC utility coverage for mAbs, biosimilars, proteins, insulins, vaccines, mRNA/LNP, HCP, sterile release, microbiology, water, cleanroom and stability workflows.

Open

Huvac — Human Vaccine QC Utilities

Huvac contains QC utilities for human vaccines: adjuvants, antigen potency, sterility, endotoxins, cold chain, mRNA controls, container closure and stability checks.

Open